BTMPS

CAS No.

52829-07-9

MDL No.

MFCD00134709

C₂₈H₅₂N₂O₄

480.70

InChI Key

XITRBUPOXXBIJN-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability
25 g	98%	$9	In Stock
4*25 g	99+%	$33	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

25 g

98%

In Stock

4*25 g

99+%

$33

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	52829-07-9
Product Name	BTMPS

Corrosive

Irritant

Health Hazard

Environmental Hazard

Acute Toxic

Signal Word:Danger

HCode:H315-H318-H319-H361-H400-H411-H330-H370-H401-H410

PCode:P203-P264-P264+P265-P273-P280-P302+P352-P305+P351+P338-P305+P354+P338-P317-P318-P321-P332+P317-P337+P317-P362+P364-P391-P405-P501-P260-P271-P284-P304+P340-P316-P320-P403+P233-P270-P308+P316

Pricing & Availability

Product Information

Safety Information

Properties

Documentation

BTMPS

Pricing & Availability

Product Information

Safety Information

Properties

Related Articles

The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seeking.

Effect of the use-dependent, nicotinic receptor antagonist BTMPS in the forced swim test and elevated plus maze after cocaine discontinuation in rats.

Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal.

Development and validation of an HPLC-MS-MS method for quantitating bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate (Tinuvin 770) and a related substance in aqueous extracts of plastic materials.

Documentation

Similar Products

(2,2,6,6-Tetramethylpiperidin-4-yl) octadecanoate

1-Piperidinyloxy, 4,4'-((1,10-dioxo-1,10-decanediyl)bis(oxy))bis(2,2,6,6-tetramethyl-